Karen’s practice focuses almost exclusively on biotech and she is involved in patent drafting and prosecution for a variety of biotechnologies, including oligonucleotide technologies, nucleic acid-based screening and detection technologies, vaccine technologies and biomarker technologies. She works with a range of clients, from small start-up companies to large multi-national corporations.
Karen entered the patent profession in 2008, joining Carpmaels & Ransford in 2010. She was the recipient of the Prince Philip Scholarship at Pembroke College, Cambridge University, where she studied Natural Sciences and specialised in Biochemistry. In her final year, she won the Marketing Prize of Shell’s Technology Enterprise Programme (STEP) following a placement at a Cambridge University spin-out company that specialises in microarray technology. This experience provided her with invaluable insights into the commercialisation of scientific research.
In 2007, Karen graduated with Distinction from her doctoral studies at the Institute of Molecular Pathology in Vienna, Austria. Her research focused on the molecular mechanisms that regulate changes of cellular identity during stem cell differentiation.
- MSci and MA Natural Sciences (Cambridge)
- PhD (Institute of Molecular Pathology, Vienna)
- Chartered Patent Attorney
- European Patent Attorney
- Certificate in IP Law